NMN Dosage: What Human Trials Actually Used

Disclosure: This post contains affiliate links. We may earn a commission if you purchase through our links, at no extra cost to you.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

NMN dosage in the nine human trials reviewed here runs from 250 mg to 2,000 mg per day, in studies of 14 to 80 people lasting anywhere from two weeks to 24 weeks. Those numbers describe what researchers tested. They are not a dose I can recommend, and no label or blog post can tell you what is right for your body.

NMN (nicotinamide mononucleotide) is a compound the body ultimately converts to NAD+, a cofactor that many metabolic enzymes use. I am not a doctor, so this guide sticks to what the trials report: who took NMN, how much, for how long, what the researchers measured, and where the evidence stops. My NAD+ vs NMN comparison covers the background if you want it first.

Table of Contents

What NMN dosage did human trials use?

Most of the trials reviewed here fall into three groups: a fixed 250 mg a day, a side by side comparison of several daily doses, and very high doses of a pharmaceutical grade version. Every one of them was small, and several had authors or funders tied to NMN makers, which I note below.

Trials of 250 mg per day

This is the most common dose in the trials reviewed here. A 2021 Science trial randomized 25 postmenopausal women with prediabetes who were overweight or obese (13 on 250 mg a day of NMN, 12 on placebo) for 10 weeks. Insulin-stimulated glucose disposal in muscle improved on NMN but not on placebo. The authors disclosed patent ties to NMN companies.

A 2022 npj Aging trial gave 250 mg a day for 6 or 12 weeks to healthy older men. Blood NAD+ levels rose. Gait speed and left grip strength improved nominally, and the authors say those results need larger studies. Body composition did not change. After a supplier error, 22 of the 42 randomized men received the wrong supplement at the 6 week visit, and their 12 week data were excluded. The authors list this as a limitation. Three authors are employees of Mitsubishi Corporation Life Sciences.

Two more trials used the same dose in healthy adults. In a 12 week trial of 30 people, 250 mg a day raised blood NAD+ with no abnormalities in the lab tests the researchers ran. Mitsubishi employees prepared the NMN and placebo. In a 12 week trial of 36 middle-aged adults, people took 125 mg twice a day. Arterial stiffness tended to fall on NMN, but the difference from placebo was not statistically significant. All authors are at DHC Corporation Laboratories, which funded the work.

The same dose did not help everyone. A 24 week trial of 14 older men with diabetes and weak grip strength or slow walking found no difference from placebo in grip strength or walking speed.

Trials comparing 300 mg, 600 mg, 900 mg and 1,200 mg

Two trials of standard NMN compared several daily doses against each other. A 2023 GeroScience trial randomized 80 healthy middle-aged adults to placebo, 300 mg, 600 mg or 900 mg once daily for 60 days. Blood NAD levels rose in every NMN group and were highest at 600 mg and 900 mg. Six minute walking distance improved on all three doses compared with placebo, with the longest distances at 600 mg and 900 mg. The authors reported no safety issues. The trial was funded and co-sponsored by Aba Chemicals and Abinopharm, which manufactured the NMN.

A 2021 trial in 48 recreational runners tested 300 mg, 600 mg and 1,200 mg a day for six weeks alongside training. Measures of oxygen use at set intensities improved more in the 600 mg and 1,200 mg groups than in the placebo group. Peak aerobic capacity did not differ.

Trials of 1,000 mg once or twice a day

The highest doses come from trials of MIB-626, a pharmaceutical grade NMN made by Metro International Biotech, whose employees are co-authors. In a 14 day trial of 32 overweight or obese adults aged 55 to 80, 1,000 mg once or twice daily raised blood NAD in a dose-related way.

A 28 day trial of 30 overweight or obese adults aged 45 and older gave 1,000 mg twice daily, which is 2,000 mg a day. The NMN group’s body weight dropped 1.9 kg more than placebo, and diastolic blood pressure and cholesterol fell too. Muscle strength, aerobic capacity and insulin sensitivity did not differ. The authors call it a physiologic study and say the data provide the rationale for larger trials. One 28 day trial of 30 people is not proof of a weight loss effect.

Does a higher NMN dose work better?

The research does not show that more is better. In the 80 person dose comparison, blood NAD levels and walking distance were highest at 600 mg and 900 mg, and the authors describe the benefit as peaking around 600 mg a day. That is one 60 day trial. The 250 mg trials above show effects on blood NAD+ and, in some cases, some changes in muscle insulin sensitivity at a much lower dose. The 2,000 mg trial did show the weight, blood pressure and cholesterol changes above, in a different population, but did not beat placebo on strength or insulin sensitivity.

Dosage choice is a clinical question when you take medication, have diabetes or blood pressure concerns, or are pregnant or nursing. A clinician who knows your history can weigh those trials against your health. My NMN side effects guide covers what trial participants reported.

Can NMN be sold as a dietary supplement in the US?

FDA says NMN is not excluded from the dietary supplement definition, as of the FDA documents read on October 20, 2026. In a letter dated December 2, 2025, the FDA wrote that it had “determined that NMN is not excluded from the dietary supplement definition.” That reversed a November 2022 position that NMN was excluded because of drug research on it. It does not clear every product: products still have to meet the other supplement rules, and FDA can still act on adulterated or misbranded ones.

The letter points to the agency’s September 29, 2025 response to a citizen petition from the Natural Products Association and the Alliance for Natural Health USA. Those documents settle a legal definition. They say nothing about which dose works, so they should not be read as a dosing guide.

What these trials did and did not measure

Most of the trials above had one clear finding: blood NAD or related metabolites went up. That shows oral NMN raised those levels. It does not show you will feel or look different. Outcomes like walking distance, grip strength, or insulin sensitivity were each measured in specific groups, such as older men, postmenopausal women with prediabetes, or amateur runners. One trial’s result in one group is not a prediction for another.

The trials also ran from two weeks to 24 weeks. None tells us what happens after years of taking a given dose. If you are hoping NMN will help with weight, the honest summary is that the one trial reviewed here that showed a weight difference was a 30 person, 28 day study of a 2,000 mg daily pharmaceutical product, and a separate trial at 250 mg found no change in body composition.

If you are also reading about injections and IV drips, I wrote separately about NAD+ injection benefits, which is a different product with a different evidence base.

How do supplement labels compare with trial doses?

The trials above report milligrams of NMN per day. A supplement label reports milligrams per serving, and a serving can be one capsule or several. The supplement facts panel is where the serving size and the amount per serving sit, so that is where to check before you compare any product with a number in a study. The trials used specific preparations, including a pharmaceutical grade tablet in the highest dose studies, so a capsule from a store shelf is not automatically the same thing. Matching a trial dose is not a recommendation.

Talk to a clinician first

This is research, not medical advice. Take your questions about NMN and your own dose to a licensed clinician or pharmacist, especially if you take prescription medication, are pregnant or breastfeeding, or manage a condition like diabetes or high blood pressure. They can tell you whether a supplement makes sense next to everything else you take.

Frequently Asked Questions

What is the standard NMN dosage?

There is no standard. The trials reviewed here used 250 mg a day most often, with others testing 300 mg to 1,200 mg and two pharmaceutical grade studies using 1,000 mg once or twice a day. Researchers chose those amounts for their studies, not as a recommendation.

How much NMN did the studies give per day?

The range was 250 mg to 2,000 mg per day. The 2,000 mg figure came from 1,000 mg twice daily in a 28 day study of 30 overweight or obese adults.

How long did the NMN dosage trials last?

From 14 days to 24 weeks. The shortest was a 14 day study of 32 adults, the longest a 24 week study of 14 older men with diabetes, and most ran 6 to 12 weeks.

Is a higher NMN dose safer or more effective?

Not on this evidence. Blood NAD rose with dose, but outcomes like walking distance peaked around 600 mg in one 60 day trial, and the very high dose trial found no strength or insulin gains.

Can I take NMN if I am on medication?

That is a question for your prescriber or pharmacist. The trials enrolled specific groups, such as healthy adults, older men or women with prediabetes, so they cannot tell you how NMN fits next to your own prescriptions.

Sources